---
title: 'The Ins and Outs of Dopamine Transporter Gene Manipulation: In Vivo Models
  of DAT Dysfunction.**DOI:** 10.1007/978-3-031-96364-3_10'
authors:
- AdeleStewart
- Randy DBlakely
journal: Advances in neurobiology
doi: 10.1007/978-3-031-96364-3_10
publication_date: ''
source: Processed from scraped content
processing_date: '2025-10-21T22:15:10.061370'
content_type: research_paper
conditions:
- adhd
- asd
- related_disorders
topics:
- neurochemistry
- hormones_endocrine
categories:
- adhd
- asd
- related-disorders
- neurochemistry
- hormones-endocrine
reading_level: academic
audience:
- professional
- researcher
patient_friendly: false
search_priority: standard
keywords:
- clinical
- behavioral
search_tags:
- asd
- adhd
- related_disorders
- peer-reviewed
- academic
- research
- hormones_endocrine
- neurochemistry
---

# The Ins and Outs of Dopamine Transporter Gene Manipulation: In Vivo Models of DAT Dysfunction.**DOI:** 10.1007/978-3-031-96364-3_10

**Authors:** AdeleStewart, Randy DBlakely

**Journal:** Advances in neurobiology

**DOI:** 10.1007/978-3-031-96364-3_10

## Abstract

The clinical efficacy of psychostimulant drugs, which target monoamine transporters, in treating attention-deficit/hyperactivity disorders (ADHDs) has stimulated interest on the role of transporter proteins like the dopamine (DA) transporter (DAT) in neurotransmission as well as the potential utility of DAT knockout organisms as models for neuropsychiatric disorders. Indeed, the study of DAT-deficient worms, flies, fish, mice, and rats has revealed a conserved role for DAT in the control of motor behavior as well as repetitive behavior, threat aversion, social behavior, and cognition in mammals. However, the disconnect between phenotypes observed in DAT-deficient model organisms and humans, which exhibit an early-onset syndrome characterized by Parkinsonism/dystonia and premature death, challenges the construct validity of DAT knockout models with respect to modeling neurobehavioral disorders. As an alternate approach, several groups have utilized coding variants in the SLC6A3 gene linked to psychiatric conditions, which display divergent molecular phenotypes. This chapter reviews the development and characterization of models of DAT gene deletion and mutation with a particular emphasis on comparing/contrasting the functional impact of DAT deficiency to DAT dysregulation triggered by neuropsychiatric disorder-linked DAT mutants in vivo. Ultimately, the study of DAT knockout and mutant models has revealed novel functions for DA in the mammalian brain, uncovered a dynamic interplay between the monoaminergic systems, highlighted sex differences in the DA system that determine the behavioral trajectory of DAT deregulation, and allowed for the screening of potential leads for therapeutics to treat disorders linked to aberrant dopaminergic neurotransmission.

**Date:** 2025-10-06
**Category:** adhd
**Source:** pubmed
**Scraped at:** 2025-10-21T11:01:16.403817
**Source URL:** https://doi.org/10.1007/978-3-031-96364-3_10## AbstractThe clinical efficacy of psychostimulant drugs, which target monoamine transporters, in treating attention-deficit/hyperactivity disorders (ADHDs) has stimulated interest on the role of transporter proteins like the dopamine (DA) transporter (DAT) in neurotransmission as well as the potential utility of DAT knockout organisms as models for neuropsychiatric disorders. Indeed, the study of DAT-deficient worms, flies, fish, mice, and rats has revealed a conserved role for DAT in the control of motor behavior as well as repetitive behavior, threat aversion, social behavior, and cognition in mammals. However, the disconnect between phenotypes observed in DAT-deficient model organisms and humans, which exhibit an early-onset syndrome characterized by Parkinsonism/dystonia and premature death, challenges the construct validity of DAT knockout models with respect to modeling neurobehavioral disorders. As an alternate approach, several groups have utilized coding variants in the SLC6A3 gene linked to psychiatric conditions, which display divergent molecular phenotypes. This chapter reviews the development and characterization of models of DAT gene deletion and mutation with a particular emphasis on comparing/contrasting the functional impact of DAT deficiency to DAT dysregulation triggered by neuropsychiatric disorder-linked DAT mutants in vivo. Ultimately, the study of DAT knockout and mutant models has revealed novel functions for DA in the mammalian brain, uncovered a dynamic interplay between the monoaminergic systems, highlighted sex differences in the DA system that determine the behavioral trajectory of DAT deregulation, and allowed for the screening of potential leads for therapeutics to treat disorders linked to aberrant dopaminergic neurotransmission.## Full Text ContentAdele Stewart3,4&Randy D. Blakely5,6Part of the book series:Advances in Neurobiology((NEUROBIOL,volume 46))121AccessesAbstractThe clinical efficacy of psychostimulant drugs, which target monoamine transporters, in treating attention-deficit/hyperactivity disorders (ADHDs) has stimulated interest on the role of transporter proteins like the dopamine (DA) transporter (DAT) in neurotransmission as well as the potential utility of DAT knockout organisms as models for neuropsychiatric disorders. Indeed, the study of DAT-deficient worms, flies, fish, mice, and rats has revealed a conserved role for DAT in the control of motor behavior as well as repetitive behavior, threat aversion, social behavior, and cognition in mammals. However, the disconnect between phenotypes observed in DAT-deficient model organisms and humans, which exhibit an early-onset syndrome characterized by Parkinsonism/dystonia and premature death, challenges the construct validity of DAT knockout models with respect to modeling neurobehavioral disorders. As an alternate approach, several groups have utilized coding variants in theSLC6A3gene linked to psychiatric conditions, which display divergent molecular phenotypes. This chapter reviews the development and characterization of models of DAT gene deletion and mutation with a particular emphasis on comparing/contrasting the functional impact of DAT deficiency to DAT dysregulation triggered by neuropsychiatric disorder-linked DAT mutants in vivo. Ultimately, the study of DAT knockout and mutant models has revealed novel functions for DA in the mammalian brain, uncovered a dynamic interplay between the monoaminergic systems, highlighted sex differences in the DA system that determine the behavioral trajectory of DAT deregulation, and allowed for the screening of potential leads for therapeutics to treat disorders linked to aberrant dopaminergic neurotransmission.This is a preview of subscription content,log in via an institutionto check access.Access this chapterLog in via an institutionSubscribe and saveSpringer+from $39.99 /MonthStarting from 10 chapters or articles per monthAccess and download chapters and articles from more than 300k books and 2,500 journalsCancel anytimeView plansBuy NowChapterUSD 29.95Price excludes VAT (USA)Available as PDFRead on any deviceInstant downloadOwn it foreverBuy ChaptereBookUSD 169.00Price excludes VAT (USA)Available as EPUB and PDFRead on any deviceInstant downloadOwn it foreverBuy eBookHardcover BookUSD 219.99Price excludes VAT (USA)Durable hardcover editionDispatched in 3 to 5 business daysFree shipping worldwide -see infoBuy Hardcover BookTax calculation will be finalised at checkoutPurchases are for personal use onlyInstitutional subscriptionsExplore related subjectsDiscover the latest articles, books and news in related subjects, suggested using machine learning.Behavioral GeneticsDevelopmental DisabilitiesHuntington's diseaseProtein TransportTransport receptorsTransporters in the nervous systemReferencesGerman DC, Schlusselberg DS, Woodward DJ (1983) Three-dimensional computer reconstruction of midbrain dopaminergic neuronal populations: from mouse to man. J Neural Transm 57:243–254ArticleCASPubMedGoogle ScholarArbuthnott GW, Wickens J (2007) Space, time and dopamine. Trends Neurosci 30:62–69ArticleCASPubMedGoogle ScholarCox J, Witten IB (2019) Striatal circuits for reward learning and decision-making. Nat Rev Neurosci 20:482–494ArticleCASPubMedPubMed CentralGoogle ScholarMorales M, Margolis EB (2017) Ventral tegmental area: cellular heterogeneity, connectivity and behaviour. Nat Rev Neurosci 18:73–85ArticleCASPubMedGoogle ScholarWalker QD, Rooney MB, Wightman RM, Kuhn CM (2000) Dopamine release and uptake are greater in female than male rat striatum as measured by fast cyclic voltammetry. Neuroscience 95:1061–1070ArticleCASPubMedGoogle ScholarCalipari ES et al (2017) Dopaminergic dynamics underlying sex-specific cocaine reward. Nat Commun 8:13877ArticleCASPubMedPubMed CentralGoogle ScholarBrundage JN et al (2021) Regional and sex differences in spontaneous striatal dopamine transmission. J Neurochem 160:598ArticlePubMedPubMed CentralGoogle ScholarDewing P et al (2006) Direct regulation of adult brain function by the male-specific factor SRY. Curr Biol 16:415–420ArticleCASPubMedGoogle ScholarDluzen DE, McDermott JL (2008) Sex differences in dopamine- and vesicular monoamine-transporter functions. Ann N Y Acad Sci 1139:140–150ArticleCASPubMedGoogle ScholarWalker QD, Ray R, Kuhn CM (2006) Sex differences in neurochemical effects of dopaminergic drugs in rat striatum. Neuropsychopharmacology 31:1193–1202ArticleCASPubMedGoogle ScholarGogos A, Ney LJ, Seymour N, Van Rheenen TE, Felmingham KL (2019) Sex differences in schizophrenia, bipolar disorder, and post-traumatic stress disorder: are gonadal hormones the link? Br J Pharmacol 176:4119–4135ArticleCASPubMedPubMed CentralGoogle ScholarMowlem FD et al (2019) Sex differences in predicting ADHD clinical diagnosis and pharmacological treatment. Eur Child Adolesc Psychiatry 28:481–489ArticlePubMedGoogle ScholarBecker JB, McClellan ML, Reed BG (2017) Sex differences, gender and addiction. J Neurosci Res 95:136–147ArticleCASPubMedPubMed CentralGoogle ScholarGottgens I et al (2020) The impact of sex and gender on the multidisciplinary management of care for persons with Parkinson’s disease. Front Neurol 11:576121ArticlePubMedPubMed CentralGoogle ScholarIversen LL (1973) Catecholamine uptake processes. Br Med Bull 29:130–135ArticleCASPubMedGoogle ScholarShimada S et al (1991) Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science 254:576–578ArticleCASPubMedGoogle ScholarKilty JE, Lorang D, Amara SG (1991) Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science 254:578–579ArticleCASPubMedGoogle ScholarGiros B, el Mestikawy S, Bertrand L, Caron MG (1991) Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett 295:149–154ArticleCASPubMedGoogle ScholarGiros B et al (1992) Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol Pharmacol 42:383–390ArticleCASPubMedGoogle ScholarReith MEA et al (2022) The dopamine transporter gene SLC6A3: multidisease risks. Mol Psychiatry 27:1031–1046ArticleCASPubMedGoogle ScholarHansen FH et al (2014) Missense dopamine transporter mutations associate with adult parkinsonism and ADHD. J Clin Invest 124:3107–3120ArticleCASPubMedPubMed CentralGoogle ScholarNg J et al (2014) Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood. Brain 137:1107–1119ArticlePubMedPubMed CentralGoogle ScholarKurian MA et al (2009) Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia. J Clin Invest 119:1595–1603CASPubMedPubMed CentralGoogle ScholarKurian MA et al (2011) Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study. Lancet Neurol 10:54–62ArticleCASPubMedGoogle ScholarGiros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606–612ArticleCASPubMedGoogle ScholarLeo D et al (2018) Pronounced hyperactivity, cognitive dysfunctions, and BDNF dysregulation in dopamine transporter knock-out rats. J Neurosci Off J Soc Neurosci 38:1959–1972ArticleCASGoogle ScholarRudnick G (1998) Ion-coupled neurotransmitter transport: thermodynamic vs. kinetic determinations of stoichiometry. Methods Enzymol 296:233–247ArticleCASPubMedGoogle ScholarPenmatsa A, Wang KH, Gouaux E (2013) X-ray structure of dopamine transporter elucidates antidepressant mechanism. Nature 503:85–90ArticleCASPubMedPubMed CentralGoogle ScholarYamashita A, Singh SK, Kawate T, Jin Y, Gouaux E (2005) Crystal structure of a bacterial homologue of Na+/Cl−-dependent neurotransmitter transporters. Nature 437:215–223ArticleCASPubMedGoogle ScholarSingh SK, Piscitelli CL, Yamashita A, Gouaux E (2008) A competitive inhibitor traps LeuT in an open-to-out conformation. Science 322:1655–1661ArticleCASPubMedPubMed CentralGoogle ScholarKrishnamurthy H, Gouaux E (2012) X-ray structures of LeuT in substrate-free outward-open and apo inward-open states. Nature 481:469–474ArticleCASPubMedPubMed CentralGoogle ScholarHerborg F, Andreassen TF, Berlin F, Loland CJ, Gether U (2018) Neuropsychiatric disease-associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes. J Biol Chem 293:7250–7262ArticleCASPubMedPubMed CentralGoogle ScholarSakrikar D et al (2012) Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation. J Neurosci Off J Soc Neurosci 32:5385–5397ArticleCASGoogle ScholarCampbell NG et al (2019) Structural, functional, and behavioral insights of dopamine dysfunction revealed by a deletion in SLC6A3. Proc Natl Acad Sci USA 116:3853–3862ArticleCASPubMedPubMed CentralGoogle ScholarHerborg F et al (2021) Identifying dominant-negative actions of a dopamine transporter variant in patients with parkinsonism and neuropsychiatric disease. JCI Insight 6:e151496ArticlePubMedPubMed CentralGoogle ScholarCartier E et al (2015) Rare autism-associated variants implicate syntaxin 1 (STX1 R26Q) phosphorylation and the dopamine transporter (hDAT R51W) in dopamine neurotransmission and behaviors. EBioMedicine 2:135–146ArticlePubMedPubMed CentralGoogle ScholarMazei-Robison MS et al (2008) Anomalous dopamine release associated with a human dopamine transporter coding variant. J Neurosci Off J Soc Neurosci 28:7040–7046ArticleCASGoogle ScholarDiCarlo GE et al (2019) Autism-linked dopamine transporter mutation alters striatal dopamine neurotransmission and dopamine-dependent behaviors. J Clin Invest 129:3407–3419ArticlePubMedPubMed CentralGoogle ScholarHamilton PJ et al (2013) De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder. Mol Psychiatry 18:1315–1323ArticleCASPubMedPubMed CentralGoogle ScholarBowton E et al (2014) SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking. Transl Psychiatry 4:e464ArticleCASPubMedPubMed CentralGoogle ScholarMazei-Robison MS, Couch RS, Shelton RC, Stein MA, Blakely RD (2005) Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder. Neuropharmacology 49:724–736ArticleCASPubMedGoogle ScholarGrunhage F et al (2000) Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1). Mol Psychiatry 5:275–282ArticleCASPubMedGoogle ScholarLovell PV, Kasimi B, Carleton J, Velho TA, Mello CV (2015) Living without DAT: loss and compensation of the dopamine transporter gene in sauropsids (birds and reptiles). Sci Rep 5:14093ArticleCASPubMedPubMed CentralGoogle ScholarChase DL, Pepper JS, Koelle MR (2004) Mechanism of extrasynaptic dopamine signaling in Caenorhabditis elegans. Nat Neurosci 7:1096–1103ArticleCASPubMedGoogle ScholarSulston J, Dew M, Brenner S (1975) Dopaminergic neurons in the nematode Caenorhabditis elegans. J Comp Neurol 163:215–226ArticleCASPubMedGoogle ScholarJayanthi LD et al (1998) The Caenorhabditis elegans gene T23G5.5 encodes an antidepressant- and cocaine-sensitive dopamine transporter. Mol Pharmacol 54:601–609ArticleCASPubMedGoogle ScholarNass R, Hall DH, Miller DM 3rd, Blakely RD (2002) Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans. Proc Natl Acad Sci USA 99:3264–3269ArticleCASPubMedPubMed CentralGoogle ScholarFormisano R, Rosikon KD, Singh A, Dhillon HS (2022) The dopamine membrane transporter plays an active modulatory role in synaptic dopamine homeostasis. J Neurosci Res 100:1551–1559ArticleCASPubMedGoogle ScholarRobinson SB et al (2017) Sequence determinants of the Caenhorhabditis elegans dopamine transporter dictating in vivo axonal export and synaptic localization. Mol Cell Neurosci 78:41–51ArticleCASPubMedGoogle ScholarPorzgen P, Park SK, Hirsh J, Sonders MS, Amara SG (2001) The antidepressant-sensitive dopamine transporter in Drosophila melanogaster: a primordial carrier for catecholamines. Mol Pharmacol 59:83–95CASPubMedGoogle ScholarGuo S et al (1999) Mutations in the zebrafish unmask shared regulatory pathways controlling the development of catecholaminergic neurons. Dev Biol 208:473–487ArticleCASPubMedGoogle ScholarHolzschuh J, Ryu S, Aberger F, Driever W (2001) Dopamine transporter expression distinguishes dopaminergic neurons from other catecholaminergic neurons in the developing zebrafish embryo. Mech Dev 101:237–243ArticleCASPubMedGoogle ScholarLam CS, Korzh V, Strahle U (2005) Zebrafish embryos are susceptible to the dopaminergic neurotoxin MPTP. Eur J Neurosci 21:1758–1762ArticlePubMedGoogle ScholarSallinen V et al (2009) MPTP and MPP+ target specific aminergic cell populations in larval zebrafish. J Neurochem 108:719–731ArticleCASPubMedGoogle ScholarFeng CW et al (2014) Effects of 6-hydroxydopamine exposure on motor activity and biochemical expression in zebrafish (Danio rerio) larvae. Zebrafish 11:227–239ArticleCASPubMedPubMed CentralGoogle ScholarVijayanathan Y et al (2017) 6-OHDA-lesioned adult zebrafish as a useful Parkinson’s disease model for dopaminergic neuroregeneration. Neurotox Res 32:496–508ArticleCASPubMedGoogle ScholarWu X, Gu HH (1999) Molecular cloning of the mouse dopamine transporter and pharmacological comparison with the human homologue. Gene 233:163–170ArticleCASPubMedGoogle ScholarBruss M, Wieland A, Bonisch H (1999) Molecular cloning and functional expression of the mouse dopamine transporter. J Neural Transm (Vienna) 106:657–662ArticleCASPubMedGoogle ScholarLloyd JT et al (2022) Dopamine dysregulation and altered responses to drugs affecting dopaminergic transmission in a new dopamine transporter knockout (DAT-KO) rat model. Neuroscience 491:43–64ArticleCASPubMedGoogle ScholarBenoit-Marand M, Jaber M, Gonon F (2000) Release and elimination of dopamine in vivo in mice lacking the dopamine transporter: functional consequences. Eur J Neurosci 12:2985–2992ArticleCASPubMedGoogle ScholarSalvatore MF, Calipari ES, Jones SR (2016) Regulation of tyrosine hydroxylase expression and phosphorylation in dopamine transporter-deficient mice. ACS Chem Neurosci 7:941–951ArticleCASPubMedGoogle ScholarFernagut PO et al (2003) Motor behaviour deficits and their histopathological and functional correlates in the nigrostriatal system of dopamine transporter knockout mice. Neuroscience 116:1123–1130ArticleCASPubMedGoogle ScholarWeiss S et al (2007) Functional alterations of nicotinic neurotransmission in dopamine transporter knock-out mice. Neuropharmacology 52:1496–1508ArticleCASPubMedGoogle ScholarJones SR et al (1999) Loss of autoreceptor functions in mice lacking the dopamine transporter. Nat Neurosci 2:649–655ArticleCASPubMedGoogle ScholarFauchey V, Jaber M, Caron MG, Bloch B, Le Moine C (2000) Differential regulation of the dopamine D1, D2 and D3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter. Eur J Neurosci 12:19–26ArticleCASPubMedGoogle ScholarFumagalli F, Racagni G, Colombo E, Riva MA (2003) BDNF gene expression is reduced in the frontal cortex of dopamine transporter knockout mice. Mol Psychiatry 8:898–899ArticleCASPubMedGoogle ScholarLi B, Arime Y, Hall FS, Uhl GR, Sora I (2010) Impaired spatial working memory and decreased frontal cortex BDNF protein level in dopamine transporter knockout mice. Eur J Pharmacol 628:104–107ArticleCASPubMedGoogle ScholarZhang X et al (2010) Altered neurocircuitry in the dopamine transporter knockout mouse brain. PLoS One 5:e11506ArticlePubMedPubMed CentralGoogle ScholarSanna F et al (2020) Altered sexual behavior in dopamine transporter (DAT) knockout male rats: a behavioral, neurochemical and intracerebral microdialysis study. Front Behav Neurosci 14:58ArticleCASPubMedPubMed CentralGoogle ScholarMakos MA, Kim YC, Han KA, Heien ML, Ewing AG (2009) In vivo electrochemical measurements of exogenously applied dopamine in Drosophila melanogaster. Anal Chem 81:1848–1854ArticleCASPubMedPubMed CentralGoogle ScholarUeno T, Kume K (2014) Functional characterization of dopamine transporter in vivo using Drosophila melanogaster behavioral assays. Front Behav Neurosci 8:303ArticlePubMedPubMed CentralGoogle ScholarWang G et al (2019) Abnormal behavior of zebrafish mutant in dopamine transporter is rescued by clozapine. iScience 17:325–333ArticleCASPubMedPubMed CentralGoogle ScholarMergy MA et al (2014) The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants. Proc Natl Acad Sci USA 111:E4779–E4788ArticleCASPubMedPubMed CentralGoogle ScholarBowton E et al (2010) Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder. J Neurosci Off J Soc Neurosci 30:6048–6057ArticleCASGoogle ScholarGowrishankar R et al (2018) Region-specific regulation of presynaptic dopamine homeostasis by D2 autoreceptors shapes the in vivo impact of the neuropsychiatric disease-associated DAT variant Val559. J Neurosci Off J Soc Neurosci 38:5302–5312ArticleCASGoogle ScholarStewart A et al (2022) Behaviorally penetrant, anomalous dopamine efflux exposes sex and circuit dependent regulation of dopamine transporters. Mol Psychiatry 27:4869–4880ArticleCASPubMedGoogle ScholarRickhag M et al (2013) A C-terminal PDZ domain-binding sequence is required for striatal distribution of the dopamine transporter. Nat Commun 4:1580ArticlePubMedGoogle ScholarTorres GE et al (2001) Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1. Neuron 30:121–134ArticleCASPubMedGoogle ScholarKume K, Kume S, Park SK, Hirsh J, Jackson FR (2005) Dopamine is a regulator of arousal in the fruit fly. J Neurosci Off J Soc Neurosci 25:7377–7384ArticleCASGoogle ScholarUeno T, Tomita J, Kume S, Kume K (2012) Dopamine modulates metabolic rate and temperature sensitivity in Drosophila melanogaster. PLoS One 7:e31513ArticleCASPubMedPubMed CentralGoogle ScholarKing LB et al (2016) Neurofibromin loss of function drives excessive grooming in Drosophila. G3 (Bethesda) 6:1083–1093ArticleCASPubMedGoogle ScholarPotdar S, Daniel DK, Thomas FA, Lall S, Sheeba V (2018) Sleep deprivation negatively impacts reproductive output in Drosophila melanogaster. J Exp Biol 221:jeb174771ArticlePubMedGoogle ScholarYamazaki M et al (2012) High calorie diet augments age-associated sleep impairment in Drosophila. Biochem Biophys Res Commun 417:812–816ArticleCASPubMedGoogle ScholarWalker JK, Gainetdinov RR, Mangel AW, Caron MG, Shetzline MA (2000) Mice lacking the dopamine transporter display altered regulation of distal colonic motility. Am J Physiol Gastrointest Liver Physiol 279:G311–G318ArticleCASPubMedGoogle ScholarVincent SG, Waddell AE, Caron MG, Walker JK, Fisher JT (2007) A murine model of hyperdopaminergic state displays altered respiratory control. FASEB J 21:1463–1471ArticleCASPubMedGoogle ScholarKavelaars A, Cobelens PM, Teunis MA, Heijnen CJ (2005) Changes in innate and acquired immune responses in mice with targeted deletion of the dopamine transporter gene. J Neuroimmunol 161:162–168ArticleCASPubMedGoogle ScholarGopinath A et al (2023) Who knew? Dopamine transporter activity is critical in innate and adaptive immune responses. Cells 12:269ArticleCASPubMedPubMed CentralGoogle ScholarMallien AS et al (2022) Dopamine transporter knockout rats show impaired wellbeing in a multimodal severity assessment approach. Front Behav Neurosci 16:924603ArticleCASPubMedPubMed CentralGoogle ScholarBelskaya A et al (2024) Rats lacking the dopamine transporter display inflexibility in innate and learned behavior. Biomedicines 12:1270ArticleCASPubMedPubMed CentralGoogle ScholarApryatin SA et al (2023) Antioxidant system alterations and physiological characteristics of neonatal and juvenile DAT-KO rats. J Neurosci Res 101:1651–1661ArticleCASPubMedGoogle ScholarBelov D, Fesenko Z, Efimov A, Lakstygal A, Efimova E (2022) Different sensitivity to anesthesia according to ECoG data in dopamine transporter knockout and heterozygous rats. Neurosci Lett 788:136839ArticleCASPubMedGoogle ScholarMergy MA et al (2014) Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder. Neurochem Int 73:56–70ArticleCASPubMedGoogle ScholarDiCarlo GE et al (2021) Autism-associated variant in the SLC6A3 gene alters the oral microbiome and metabolism in a murine model. Front Psych 12:655451ArticleGoogle ScholarNg J, Barral S, Waddington SN, Kurian MA (2023) Dopamine transporter deficiency syndrome (DTDS): expanding the clinical phenotype and precision medicine approaches. Cells 12:1737ArticleCASPubMedPubMed CentralGoogle ScholarMcDonald PW et al (2007) Vigorous motor activity in Caenorhabditis elegans requires efficient clearance of dopamine mediated by synaptic localization of the dopamine transporter DAT-1. J Neurosci Off J Soc Neurosci 27:14216–14227ArticleCASGoogle ScholarHardaway JA et al (2012) Forward genetic analysis to identify determinants of dopamine signaling in Caenorhabditis elegans using swimming-induced paralysis. G3 (Bethesda) 2:961–975ArticleCASPubMedGoogle ScholarRobinson SB et al (2019) Dopamine-dependent, swimming-induced paralysis arises as a consequence of loss of function mutations in the RUNX transcription factor RNT-1. PLoS One 14:e0216417ArticlePubMedPubMed CentralGoogle ScholarBermingham DP et al (2017) The atypical MAP kinase SWIP-13/ERK8 regulates dopamine transporters through a rho-dependent mechanism. J Neurosci Off J Soc Neurosci 37:9288–9304ArticleCASGoogle ScholarIlliano P et al (2017) A Caenorhabditis elegans model to study dopamine transporter deficiency syndrome. Eur J Neurosci 45:207–214ArticlePubMedGoogle ScholarUeno T, Masuda N, Kume S, Kume K (2012) Dopamine modulates the rest period length without perturbation of its power law distribution in Drosophila melanogaster. PLoS One 7:e32007ArticleCASPubMedPubMed CentralGoogle ScholarSpielewoy C et al (2000) Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice. Behav Pharmacol 11:279–290ArticleCASPubMedPubMed CentralGoogle ScholarPerona MT et al (2008) Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions. Behav Pharmacol 19:566–574ArticleCASPubMedPubMed CentralGoogle ScholarMorice E, Denis C, Giros B, Nosten-Bertrand M (2004) Phenotypic expression of the targeted null-mutation in the dopamine transporter gene varies as a function of the genetic background. Eur J Neurosci 20:120–126ArticlePubMedGoogle ScholarCarpenter AC, Saborido TP, Stanwood GD (2012) Development of hyperactivity and anxiety responses in dopamine transporter-deficient mice. Dev Neurosci 34:250–257ArticleCASPubMedGoogle ScholarRalph RJ, Paulus MP, Fumagalli F, Caron MG, Geyer MA (2001) Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists. J Neurosci Off J Soc Neurosci 21:305–313ArticleCASGoogle ScholarFerris MJ et al (2014) Dopamine transporters govern diurnal variation in extracellular dopamine tone. Proc Natl Acad Sci USA 111:E2751–E2759ArticleCASPubMedPubMed CentralGoogle ScholarGainetdinov RR et al (1999) Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283:397–401ArticleCASPubMedGoogle ScholarAdinolfi A et al (2018) Novelty-related behavior of young and adult dopamine transporter knockout rats: implication for cognitive and emotional phenotypic patterns. Genes Brain Behav 17:e12463ArticleCASPubMedGoogle ScholarKacprzak V et al (2017) Dopaminergic control of anxiety in young and aged zebrafish. Pharmacol Biochem Behav 157:1–8ArticleCASPubMedPubMed CentralGoogle ScholarPogorelov VM, Rodriguiz RM, Insco ML, Caron MG, Wetsel WC (2005) Novelty seeking and stereotypic activation of behavior in mice with disruption of the Dat1 gene. Neuropsychopharmacology 30:1818–1831ArticleCASPubMedGoogle ScholarCosta RM et al (2006) Rapid alterations in corticostriatal ensemble coordination during acute dopamine-dependent motor dysfunction. Neuron 52:359–369ArticleCASPubMedGoogle ScholarBerlanga ML et al (2011) Multiscale imaging characterization of dopamine transporter knockout mice reveals regional alterations in spine density of medium spiny neurons. Brain Res 1390:41–49ArticleCASPubMedPubMed CentralGoogle ScholarFox MA, Panessiti MG, Hall FS, Uhl GR, Murphy DL (2013) An evaluation of the serotonin system and perseverative, compulsive, stereotypical, and hyperactive behaviors in dopamine transporter (DAT) knockout mice. Psychopharmacology 227:685–695ArticleCASPubMedGoogle ScholarAdinolfi A et al (2019) Behavioral characterization of DAT-KO rats and evidence of asocial-like phenotypes in DAT-HET rats: the potential involvement of norepinephrine system. Behav Brain Res 359:516–527ArticleCASPubMedGoogle ScholarStewart A et al (2022) Male DAT Val559 mice exhibit compulsive behavior under devalued reward conditions accompanied by cellular and pharmacological changes. Cells 11:4059ArticleCASPubMedPubMed CentralGoogle ScholarKurzina NP, Aristova IY, Volnova AB, Gainetdinov RR (2020) Deficit in working memory and abnormal behavioral tactics in dopamine transporter knockout rats during training in the 8-arm maze. Behav Brain Res 390:112642ArticleCASPubMedGoogle ScholarWeiss S, Nosten-Bertrand M, McIntosh JM, Giros B, Martres MP (2007) Nicotine improves cognitive deficits of dopamine transporter knockout mice without long-term tolerance. Neuropsychopharmacology 32:2465–2478ArticleCASPubMedGoogle ScholarDeng S et al (2015) A behavioral defect of temporal association memory in mice that partly lack dopamine reuptake transporter. Sci Rep 5:17461ArticleCASPubMedPubMed CentralGoogle ScholarDel’Guidice T et al (2014) Dissociations between cognitive and motor effects of psychostimulants and atomoxetine in hyperactive DAT-KO mice. Psychopharmacology 231:109–122ArticlePubMedGoogle ScholarWong P, Sze Y, Chang CC, Lee J, Zhang X (2015) Pregnenolone sulfate normalizes schizophrenia-like behaviors in dopamine transporter knockout mice through the AKT/GSK3beta pathway. Transl Psychiatry 5:e528ArticleCASPubMedPubMed CentralGoogle ScholarLi F, Wang LP, Shen X, Tsien JZ (2010) Balanced dopamine is critical for pattern completion during associative memory recall. PLoS One 5:e15401ArticlePubMedPubMed CentralGoogle ScholarMereu M et al (2017) Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder. Neuropharmacology 121:179–194ArticleCASPubMedGoogle ScholarCybulska-Klosowicz A, Laczkowska M, Zakrzewska R, Kaliszewska A (2017) Attentional deficits and altered neuronal activation in medial prefrontal and posterior parietal cortices in mice with reduced dopamine transporter levels. Mol Cell Neurosci 85:82–92ArticleCASPubMedGoogle ScholarCybulska-Klosowicz A, Dabrowska J, Niedzielec S, Zakrzewska R, Rozycka A (2017) Potential role of dopamine transporter in behavioral flexibility. Acta Neurobiol Exp (Wars) 77:176–189ArticlePubMedGoogle ScholarTakamatsu Y et al (2015) Improvement of learning and increase in dopamine level in the frontal cortex by methylphenidate in mice lacking dopamine transporter. Curr Mol Med 15:245–252ArticleCASPubMedPubMed CentralGoogle ScholarPowell SB, Young JW, Ong JC, Caron MG, Geyer MA (2008) Atypical antipsychotics clozapine and quetiapine attenuate prepulse inhibition deficits in dopamine transporter knockout mice. Behav Pharmacol 19:562–565ArticleCASPubMedPubMed CentralGoogle ScholarYamashita M et al (2013) Impaired cliff avoidance reaction in dopamine transporter knockout mice. Psychopharmacology 227:741–749ArticleCASPubMedGoogle ScholarHironaka N, Ikeda K, Sora I, Uhl GR, Niki H (2004) Food-reinforced operant behavior in dopamine transporter knockout mice: enhanced resistance to extinction. Ann N Y Acad Sci 1025:140–145ArticleCASPubMedGoogle ScholarRossi MA, Yin HH (2015) Elevated dopamine alters consummatory pattern generation and increases behavioral variability during learning. Front Integr Neurosci 9:37ArticlePubMedPubMed CentralGoogle ScholarMeck WH et al (2012) Gene-dose dependent effects of methamphetamine on interval timing in dopamine-transporter knockout mice. Neuropharmacology 62:1221–1229ArticleCASPubMedGoogle ScholarSavelieva KV, Caudle WM, Findlay GS, Caron MG, Miller GW (2002) Decreased ethanol preference and consumption in dopamine transporter female knock-out mice. Alcohol Clin Exp Res 26:758–764ArticleCASPubMedGoogle ScholarTillerson JL et al (2006) Olfactory discrimination deficits in mice lacking the dopamine transporter or the D2 dopamine receptor. Behav Brain Res 172:97–105ArticleCASPubMedGoogle ScholarPtukha M et al (2022) Effects of atomoxetine on motor and cognitive behaviors and brain electrophysiological activity of dopamine transporter knockout rats. Biomolecules 12:1484ArticleCASPubMedPubMed CentralGoogle ScholarCinque S et al (2018) Behavioral phenotyping of dopamine transporter knockout rats: compulsive traits, motor stereotypies, and anhedonia. Front Psych 9:43ArticleGoogle ScholarSavchenko A et al (2022) The lack of dopamine transporter is associated with conditional associative learning impairments and striatal proteomic changes. Front Psych 13:799433ArticleGoogle ScholarKurzina NP, Volnova AB, Aristova IY, Gainetdinov RR (2021) A new paradigm for training hyperactive dopamine transporter knockout rats: influence of novel stimuli on object recognition. Front Behav Neurosci 15:654469ArticleCASPubMedPubMed CentralGoogle ScholarDavis GL et al (2018) Functional coding variation in the presynaptic dopamine transporter associated with neuropsychiatric disorders drives enhanced motivation and context-dependent impulsivity in mice. Behav Brain Res 337:61–69ArticlePubMedGoogle ScholarGunaydin LA et al (2014) Natural neural projection dynamics underlying social behavior. Cell 157:1535–1551ArticleCASPubMedPubMed CentralGoogle ScholarSolie C, Girard B, Righetti B, Tapparel M, Bellone C (2022) VTA dopamine neuron activity encodes social interaction and promotes reinforcement learning through social prediction error. Nat Neurosci 25:86–97ArticleCASPubMedGoogle ScholarRodriguiz RM, Chu R, Caron MG, Wetsel WC (2004) Aberrant responses in social interaction of dopamine transporter knockout mice. Behav Brain Res 148:185–198ArticleCASPubMedGoogle ScholarFan Z et al (2019) Using the tube test to measure social hierarchy in mice. Nat Protoc 14:819–831ArticleCASPubMedGoogle ScholarJavitch JA, D’Amato RJ, Strittmatter SM, Snyder SH (1985) Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci USA 82:2173–2177ArticleCASPubMedPubMed CentralGoogle ScholarNass R et al (2005) A genetic screen in Caenorhabditis elegans for dopamine neuron insensitivity to 6-hydroxydopamine identifies dopamine transporter mutants impacting transporter biosynthesis and trafficking. J Neurochem 94:774–785ArticleCASPubMedGoogle ScholarFumagalli F, Gainetdinov RR, Valenzano KJ, Caron MG (1998) Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter. J Neurosci Off J Soc Neurosci 18:4861–4869ArticleCASGoogle ScholarBezard E et al (1999) Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter. Exp Neurol 155:268–273ArticleCASPubMedGoogle ScholarNumachi Y et al (2007) Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters. Eur J Pharmacol 572:120–128ArticleCASPubMedGoogle ScholarCarvelli L, Matthies DS, Galli A (2010) Molecular mechanisms of amphetamine actions in Caenorhabditis elegans. Mol Pharmacol 78:151–156ArticleCASPubMedPubMed CentralGoogle ScholarTorres Valladares D, Kudumala S, Hossain M, Carvelli L (2020) Caenorhabditis elegans as an in vivo model to assess amphetamine tolerance. Brain Behav Evol 95:247–255ArticlePubMedGoogle ScholarPizzo AB et al (2013) The membrane raft protein Flotillin-1 is essential in dopamine neurons for amphetamine-induced behavior in Drosophila. Mol Psychiatry 18:824–833ArticleCASPubMedGoogle ScholarKaram CS, Williams BL, Jones SK, Javitch JA (2022) The role of the dopamine transporter in the effects of amphetamine on sleep and sleep architecture in Drosophila. Neurochem Res 47:177–189ArticleCASPubMedGoogle ScholarCervinski MA, Foster JD, Vaughan RA (2010) Syntaxin 1A regulates dopamine transporter activity, phosphorylation and surface expression. Neuroscience 170:408–416ArticleCASPubMedGoogle ScholarBinda F et al (2008) Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux. Mol Pharmacol 74:1101–1108ArticleCASPubMedGoogle ScholarFukushima S et al (2007) Methamphetamine-induced locomotor activity and sensitization in dopamine transporter and vesicular monoamine transporter 2 double mutant mice. Psychopharmacology 193:55–62ArticleCASPubMedGoogle ScholarJones SR, Gainetdinov RR, Wightman RM, Caron MG (1998) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci Off J Soc Neurosci 18:1979–1986ArticleCASGoogle ScholarHagino Y et al (2011) Effects of MDMA on extracellular dopamine and serotonin levels in mice lacking dopamine and/or serotonin transporters. Curr Neuropharmacol 9:91–95ArticleCASPubMedPubMed CentralGoogle ScholarBudygin EA et al (2004) Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine. Proc Natl Acad Sci USA 101:7781–7786ArticleCASPubMedPubMed CentralGoogle ScholarRocha BA et al (1998) Cocaine self-administration in dopamine-transporter knockout mice. Nat Neurosci 1:132–137ArticleCASPubMedGoogle ScholarBudygin EA, John CE, Mateo Y, Jones SR (2002) Lack of cocaine effect on dopamine clearance in the core and shell of the nucleus accumbens of dopamine transporter knock-out mice. J Neurosci 22:RC222ArticlePubMedPubMed CentralGoogle ScholarTrinh JV, Nehrenberg DL, Jacobsen JP, Caron MG, Wetsel WC (2003) Differential psychostimulant-induced activation of neural circuits in dopamine transporter knockout and wild type mice. Neuroscience 118:297–310ArticleCASPubMedGoogle ScholarThanos PK, Michaelides M, Benveniste H, Wang GJ, Volkow ND (2008) The effects of cocaine on regional brain glucose metabolism is attenuated in dopamine transporter knockout mice. Synapse 62:319–324ArticleCASPubMedPubMed CentralGoogle ScholarPerles-Barbacaru TA et al (2011) Quantitative pharmacologic MRI: mapping the cerebral blood volume response to cocaine in dopamine transporter knockout mice. NeuroImage 55:622–628ArticleCASPubMedGoogle ScholarShi X, McGinty JF (2006) Extracellular signal-regulated mitogen-activated protein kinase inhibitors decrease amphetamine-induced behavior and neuropeptide gene expression in the striatum. Neuroscience 138:1289–1298ArticleCASPubMedGoogle ScholarValjent E, Corvol JC, Trzaskos JM, Girault JA, Herve D (2006) Role of the ERK pathway in psychostimulant-induced locomotor sensitization. BMC Neurosci 7:20ArticlePubMedPubMed CentralGoogle ScholarBeaulieu JM, Sotnikova TD, Gainetdinov RR, Caron MG (2006) Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice. J Biol Chem 281:32072–32080ArticleCASPubMedGoogle ScholarMedvedev IO et al (2005) Characterization of conditioned place preference to cocaine in congenic dopamine transporter knockout female mice. Psychopharmacology 180:408–413ArticleCASPubMedGoogle ScholarThomsen M, Hall FS, Uhl GR, Caine SB (2009) Dramatically decreased cocaine self-administration in dopamine but not serotonin transporter knock-out mice. J Neurosci Off J Soc Neurosci 29:1087–1092ArticleCASGoogle ScholarMead AN, Rocha BA, Donovan DM, Katz JL (2002) Intravenous cocaine induced-activity and behavioural sensitization in norepinephrine-, but not dopamine-transporter knockout mice. Eur J Neurosci 16:514–520ArticlePubMedGoogle ScholarHall FS et al (2009) Cocaine-conditioned locomotion in dopamine transporter, norepinephrine transporter and 5-HT transporter knockout mice. Neuroscience 162:870–880ArticleCASPubMedGoogle ScholarMorice E, Denis C, Giros B, Nosten-Bertrand M (2010) Evidence of long-term expression of behavioral sensitization to both cocaine and ethanol in dopamine transporter knockout mice. Psychopharmacology 208:57–66ArticleCASPubMedGoogle ScholarPardo M, Martin M, Gainetdinov RR, Mash DC, Izenwasser S (2022) Heterozygote dopamine transporter knockout rats display enhanced cocaine locomotion in adolescent females. Int J Mol Sci 23:15414ArticleCASPubMedPubMed CentralGoogle ScholarStewart A et al (2019) Serotonin transporter inhibition and 5-HT(2C) receptor activation drive loss of cocaine-induced locomotor activation in DAT Val559 mice. Neuropsychopharmacology 44:994–1006ArticleCASPubMedGoogle ScholarSpielewoy C et al (2000) Increased rewarding properties of morphine in dopamine-transporter knockout mice. Eur J Neurosci 12:1827–1837ArticleCASPubMedPubMed CentralGoogle ScholarHall FS, Sora I, Uhl GR (2003) Sex-dependent modulation of ethanol consumption in vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) knockout mice. Neuropsychopharmacology 28:620–628ArticlePubMedGoogle ScholarCosta KM, Schenkel D, Roeper J (2021) Sex-dependent alterations in behavior, drug responses and dopamine transporter expression in heterozygous DAT-Cre mice. Sci Rep 11:3334ArticleCASPubMedPubMed CentralGoogle ScholarJi J, Dluzen DE (2008) Sex differences in striatal dopaminergic function within heterozygous mutant dopamine transporter knock-out mice. J Neural Transm (Vienna) 115:809–817ArticleCASPubMedGoogle ScholarPowell SB et al (2004) MDMA “ecstasy” alters hyperactive and perseverative behaviors in dopamine transporter knockout mice. Psychopharmacology 173:310–317ArticleCASPubMedGoogle ScholarBarr AM et al (2004) The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice. Neuropsychopharmacology 29:221–228ArticleCASPubMedGoogle ScholarHall FS, Sora I, Hen R, Uhl GR (2014) Serotonin/dopamine interactions in a hyperactive mouse: reduced serotonin receptor 1B activity reverses effects of dopamine transporter knockout. PLoS One 9:e115009ArticlePubMedPubMed CentralGoogle ScholarUchiumi O et al (2013) Serotonergic involvement in the amelioration of behavioral abnormalities in dopamine transporter knockout mice by nicotine. Neuropharmacology 64:348–356ArticleCASPubMedGoogle ScholarTraktirov DS et al (2023) Alterations in serotonin neurotransmission in hyperdopaminergic rats lacking the dopamine transporter. Biomedicines 11:2881ArticleCASPubMedPubMed CentralGoogle ScholarHan DD, Gu HH (2006) Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol 6:6ArticlePubMedPubMed CentralGoogle ScholarSora I et al (2001) Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc Natl Acad Sci USA 98:5300–5305ArticleCASPubMedPubMed CentralGoogle ScholarChen R et al (2006) Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter. Proc Natl Acad Sci USA 103:9333–9338ArticleCASPubMedPubMed CentralGoogle ScholarWu H et al (2014) Restoration of cocaine stimulation and reward by reintroducing wild type dopamine transporter in adult knock-in mice with a cocaine-insensitive dopamine transporter. Neuropharmacology 86:31–37ArticleCASPubMedPubMed CentralGoogle ScholarCarboni E et al (2001) Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene. J Neurosci Off J Soc Neurosci 21(RC141):141–144ArticleGoogle ScholarShen HW et al (2004) Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacology 29:1790–1799ArticleCASPubMedGoogle ScholarMateo Y, Budygin EA, John CE, Jones SR (2004) Role of serotonin in cocaine effects in mice with reduced dopamine transporter function. Proc Natl Acad Sci USA 101:372–377ArticleCASPubMedGoogle ScholarMateo Y, Budygin EA, John CE, Banks ML, Jones SR (2004) Voltammetric assessment of dopamine clearance in the absence of the dopamine transporter: no contribution of other transporters in core or shell of nucleus accumbens. J Neurosci Methods 140:183–187ArticleCASPubMedGoogle ScholarJohn CE, Jones SR (2006) Exocytotic release of dopamine in ventral tegmental area slices from C57BL/6 and dopamine transporter knockout mice. Neurochem Int 49:737–745ArticleCASPubMedGoogle ScholarHall FS et al (2002) Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions. Neuroscience 115:153–161ArticleCASPubMedGoogle ScholarHarris SS, Green SM, Kumar M, Urs NM (2022) A role for cortical dopamine in the paradoxical calming effects of psychostimulants. Sci Rep 12:3129ArticleCASPubMedPubMed CentralGoogle ScholarSimmler LD et al (2017) Blockade of the 5-HT transporter contributes to the behavioural, neuronal and molecular effects of cocaine. Br J Pharmacol 174:2716–2738ArticleCASPubMedPubMed CentralGoogle ScholarGainetdinov RR, Mohn AR, Bohn LM, Caron MG (2001) Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter. Proc Natl Acad Sci USA 98:11047–11054ArticleCASPubMedPubMed CentralGoogle ScholarTarga G et al (2023) Dysregulation of AMPA receptor trafficking and intracellular vesicular sorting in the prefrontal cortex of dopamine transporter knock-out rats. Biomolecules 13:516ArticleCASPubMedPubMed CentralGoogle ScholarHlavacova N et al (2023) Altered responsiveness to glutamatergic modulation by MK-801 and to repeated stress of immune challenge in female dopamine transporter knockout rats. Prog Neuro-Psychopharmacol Biol Psychiatry 126:110804ArticleCASGoogle ScholarReinwald JR et al (2022) Dopamine transporter silencing in the rat: systems-level alterations in striato-cerebellar and prefrontal-midbrain circuits. Mol Psychiatry 27:2329–2339ArticleCASPubMedPubMed CentralGoogle ScholarRefai O et al (2022) Allosteric modulator KM822 attenuates behavioral actions of amphetamine in Caenorhabditis elegans through interactions with the dopamine transporter DAT-1. Mol Pharmacol 101:123–131ArticleCASPubMedPubMed CentralGoogle ScholarReith MEA, Jones KT, Zhen J, Topiol S (2018) Latch and trigger role for R445 in DAT transport explains molecular basis of DTDS. Bioorg Med Chem Lett 28:470–475ArticleCASPubMedGoogle ScholarAguilar JI et al (2021) Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia. elife 10:e68039ArticleCASPubMedPubMed CentralGoogle ScholarBeerepoot P, Lam VM, Salahpour A (2016) Pharmacological chaperones of the dopamine transporter rescue dopamine transporter deficiency syndrome mutations in heterologous cells. J Biol Chem 291:22053–22062ArticleCASPubMedPubMed CentralGoogle ScholarSucic S et al (2016) When transporters fail to be transported: how to rescue folding-deficient SLC6 transporters. J Neurol Neuromedicine 1:34–40ArticlePubMedPubMed CentralGoogle ScholarAsjad HMM et al (2017) Pharmacochaperoning in a Drosophila model system rescues human dopamine transporter variants associated with infantile/juvenile parkinsonism. J Biol Chem 292:19250–19265ArticlePubMedPubMed CentralGoogle ScholarIlliano P et al (2017) Recombinant adeno-associated virus-mediated rescue of function in a mouse model of dopamine transporter deficiency syndrome. Sci Rep 7:46280ArticleCASPubMedPubMed CentralGoogle ScholarXu TX, Ma Q, Spealman RD, Yao WD (2010) Amphetamine modulation of long-term potentiation in the prefrontal cortex: dose dependency, monoaminergic contributions, and paradoxical rescue in hyperdopaminergic mutant. J Neurochem 115:1643–1654ArticleCASPubMedPubMed CentralGoogle ScholarArime Y, Kasahara Y, Hall FS, Uhl GR, Sora I (2012) Cortico-subcortical neuromodulation involved in the amelioration of prepulse inhibition deficits in dopamine transporter knockout mice. Neuropsychopharmacology 37:2522–2530ArticleCASPubMedPubMed CentralGoogle ScholarKurzina N et al (2022) Modulation of spatial memory deficit and hyperactivity in dopamine transporter knockout rats via alpha2A-adrenoceptors. Front Psych 13:851296ArticleGoogle ScholarVolnova A et al (2023) Noradrenergic modulation of learned and innate behaviors in dopamine transporter knockout rats by guanfacine. Biomedicines 11:222ArticleCASPubMedPubMed CentralGoogle ScholarRegan SL, Williams MT, Vorhees CV (2022) Review of rodent models of attention deficit hyperactivity disorder. Neurosci Biobehav Rev 132:621–637ArticleCASPubMedGoogle ScholarDownload referencesAcknowledgmentsSupport for this contribution derives from a Brain and Behavioral Research Foundation Young Investigator Award to A.S. and a grant from the National Institute of Mental Health (MH105994). Figures were generated withBioRender.com.Author informationAuthors and AffiliationsDepartment of Neuroscience and Pharmacology, University of Iowa, Iowa City, IA, USAAdele StewartIowa Neuroscience Institute, University of Iowa, Iowa City, IA, USAAdele StewartDepartment of Biomedical Science, Florida Atlantic University, Jupiter, FL, USARandy D. BlakelyStiles-Nicholson Brain Institute, Florida Atlantic University, Jupiter, FL, USARandy D. BlakelyAuthorsAdele StewartView author publicationsSearch author on:PubMedGoogle ScholarRandy D. BlakelyView author publicationsSearch author on:PubMedGoogle ScholarCorresponding authorsCorrespondence toAdele StewartorRandy D. Blakely.Editor informationEditors and AffiliationsDept of Pharmacology & Physiology, Drexel University College of Medicine, Philadelphia, PA, USAOle MortensenRights and permissionsReprints and permissionsCopyright information© 2025 The Author(s), under exclusive license to Springer Nature Switzerland AGAbout this chapterCite this chapterStewart, A., Blakely, R.D. (2025).  The Ins and Outs of Dopamine Transporter Gene Manipulation: In Vivo Models of DAT Dysfunction.In: Mortensen, O. (eds) Monoamine Transporters. Advances in Neurobiology, vol 46. Springer, Cham. https://doi.org/10.1007/978-3-031-96364-3_10Download citation.RIS.ENW.BIBDOI:https://doi.org/10.1007/978-3-031-96364-3_10Published:07 October 2025Publisher Name:Springer, ChamPrint ISBN:978-3-031-96363-6Online ISBN:978-3-031-96364-3eBook Packages:Biomedical and Life SciencesBiomedical and Life Sciences (R0)Share this chapterAnyone you share the following link with will be able to read this content:Get shareable linkSorry, a shareable link is not currently available for this article.Copy shareable link to clipboardProvided by the Springer Nature SharedIt content-sharing initiativeKeywordsDopamine transporterModel organismPsychostimulantsKnockoutAnimal behaviorPublish with usPolicies and ethics---
*This content was automatically scraped by Webscraping Agent A*